This page tracks new and upcoming treatment options for herpes simplex virus type 1 (HSV-1). What’s in development? What’s promising? What’s available soon? Current topics include AK-157, AK-166, UB-621, HDIT101, GSK4108771A, and more. Jump to section: News, Research, Clinical Trials, Funded Projects, Discussion.
Last updated: 2 years ago Subscribe to email updates
News
Research
- Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology Feb 12, 2024
- Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D Feb 5, 2024
- Unveiling the Antiviral Efficacy of Forskolin: A Multifaceted In Vitro and In Silico Approach Feb 3, 2024
- Herpes Simplex Virus-1 targets the 2’-3’cGAMP importer SLC19A1 as an antiviral countermeasure [Preprint] Jan 26, 2024
- Anti-herpes simplex virus activities and mechanisms of marine derived compounds Jan 8, 2024
- Lanatoside C inhibits herpes simplex virus 1 replication by regulating NRF2 distribution within cells Dec 25, 2023
- Histone H2A variant H2A.B is enriched in transcriptionally active HSV-1 lytic chromatin [Preprint] Dec 22, 2023
- Viral gene drive spread during herpes simplex virus 1 infection in mice [Preprint] Dec 8, 2023